Position in ABOS
as of Dec 31, 2025
· filed Feb 23, 2026
Position Value
$23,045
-$32,147 QoQ
Shares Held
10,922
-50.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtu Financial LLC holds $48,923,071 across 139 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
70,715 | $3,728,094 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,634 | $3,408,886 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
67,775 | $2,692,023 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
54,785 | $2,204,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,479 | $2,173,678 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
262,298 | $2,011,825 | |
| 7 | ANAB |
Anaptysbio, Inc
|
33,323 | $1,848,093 | |
| 8 | ABVX |
Abivax S.A.
|
9,551 | $1,063,503 |
All Filings in ABOS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $23,045 | 10,922 | Shares | Defined | 2026-02-23 | |
| 2024-09-30 | $55,192 | 22,255 | Shares | Defined | 2024-11-20 | |
| 2024-06-30 | $59,052 | 24,402 | Shares | Defined | 2024-08-09 | |
| 2023-12-31 | $91,342 | 23,787 | Shares | Defined | 2024-02-26 | |
| 2022-06-30 | $123,158 | 26,204 | Shares | Defined | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||